138 related articles for article (PubMed ID: 34180325)
21. Two new 3-hexenol glycosides from the calyces of
Shu Z; Tang Y; Yang Y; Ding Z; Zhong R; Xia T; Li X; Zheng C; Wen Z; Li W; Wang Y
Nat Prod Res; 2021 Apr; 35(8):1274-1280. PubMed ID: 31343265
[TBL] [Abstract][Full Text] [Related]
22.
Zhang CY; Luo JG; Liu RH; Lin R; Yang MH; Kong LY
Fitoterapia; 2016 Oct; 114():138-143. PubMed ID: 27642039
[TBL] [Abstract][Full Text] [Related]
23. New sesquiterpenoids with COX-2 inhibitory activity from the medical plant Physalis. alkekengi L. var. franchetii.
Zhang JL; Zhou FF; Li YZ; Feng T; Jiang LL; Jiang RW; Zhang XX; Li XD
Fitoterapia; 2020 Mar; 141():104470. PubMed ID: 31917300
[TBL] [Abstract][Full Text] [Related]
24. Steroids and flavonoids from Physalis alkekengi var. franchetii and their inhibitory effects on nitric oxide production.
Qiu L; Zhao F; Jiang ZH; Chen LX; Zhao Q; Liu HX; Yao XS; Qiu F
J Nat Prod; 2008 Apr; 71(4):642-6. PubMed ID: 18348534
[TBL] [Abstract][Full Text] [Related]
25. Physakengoses K-Q, seven new sucrose esters from Physalis alkekengi var. franchetii.
Zhang CY; Luo JG; Liu RH; Lin R; Yang MH; Kong LY
Carbohydr Res; 2017 Sep; 449():120-124. PubMed ID: 28779658
[TBL] [Abstract][Full Text] [Related]
26. In vivo effects on the intestinal microflora of Physalis alkekengi var. francheti extracts.
Li X; Zhang C; Li W; Wu D; Liu J; Tang L; Xin Y
Fitoterapia; 2013 Jun; 87():43-8. PubMed ID: 23562629
[TBL] [Abstract][Full Text] [Related]
27. Physalis alkekengi L. var. franchetii combined with hormone therapy for atopic dermatitis.
Yang M; Zhao M; Xia T; Chen Y; Li W; Zhang H; Peng M; Li C; Cao X; Liang L; Yue Y; Zhong L; Du J; Li J; Wang Y; Shu Z
Biomed Pharmacother; 2023 Jun; 162():114622. PubMed ID: 37003035
[TBL] [Abstract][Full Text] [Related]
28. Quantitative and transformation product analysis of major active physalins from Physalis alkekengi var. franchetii (Chinese lantern) using ultraperformance liquid chromatography with electrospray ionisation tandem mass spectrometry and time-of-flight mass spectrometry.
Zheng Y; Chen Y; Ren Y; Luan L; Wu Y
Phytochem Anal; 2012; 23(4):337-44. PubMed ID: 21997776
[TBL] [Abstract][Full Text] [Related]
29. In vitro effects on intestinal bacterium of physalins from Physalis alkekengi var. Francheti.
Li X; Zhang C; Wu D; Tang L; Cao X; Xin Y
Fitoterapia; 2012 Dec; 83(8):1460-5. PubMed ID: 22940088
[TBL] [Abstract][Full Text] [Related]
30. Anti-Inflammatory Effect of Three Isolated Compounds of
Park HJ; Shim HS; Han AR; Seo EK; Kim KR; Han BH; Shim I
Curr Issues Mol Biol; 2022 Mar; 44(3):1407-1416. PubMed ID: 35723317
[TBL] [Abstract][Full Text] [Related]
31. Physalins V-IX, 16,24-cyclo-13,14-seco withanolides from Physalis angulata and their antiproliferative and anti-inflammatory activities.
Sun CP; Qiu CY; Zhao F; Kang N; Chen LX; Qiu F
Sci Rep; 2017 Jun; 7(1):4057. PubMed ID: 28642618
[TBL] [Abstract][Full Text] [Related]
32. Non-targeted chromatographic analyses of cuticular wax flavonoids from Physalis alkekengi L.
Kranjc E; Albreht A; Vovk I; Makuc D; Plavec J
J Chromatogr A; 2016 Mar; 1437():95-106. PubMed ID: 26875116
[TBL] [Abstract][Full Text] [Related]
33. Physalis alkekengi L. var. franchetii (Mast.) Makino: A review of the pharmacognosy, chemical constituents, pharmacological effects, quality control, and applications.
Liang L; Li C; Wang Y; Yue Y; Zhang H; Yang M; Cao X; Zhao M; Du J; Peng M; Chen Y; Li W; Xia T; Zhong R; Shu Z
Phytomedicine; 2022 Oct; 105():154328. PubMed ID: 35908519
[TBL] [Abstract][Full Text] [Related]
34. Two new megastigmane glycosides, physanosides A and B, from Physalis alkekengi L. var. franchetii, and their effect on NO release in macrophages.
Qiu L; Zhao F; Liu H; Chen L; Jiang Z; Liu H; Wang N; Yao X; Qiu F
Chem Biodivers; 2008 May; 5(5):758-63. PubMed ID: 18493962
[TBL] [Abstract][Full Text] [Related]
35. Systems pharmacology reveals the mechanism of activity of Physalis alkekengi L. var. franchetii against lipopolysaccharide-induced acute lung injury.
Yang Y; Ding Z; Wang Y; Zhong R; Feng Y; Xia T; Xie Y; Yang B; Sun X; Shu Z
J Cell Mol Med; 2020 May; 24(9):5039-5056. PubMed ID: 32220053
[TBL] [Abstract][Full Text] [Related]
36. Induction of quinone reductase (QR) by withanolides isolated from Physalis pubescens L. (Solanaceae).
Ji L; Yuan Y; Ma Z; Chen Z; Gan L; Ma X; Huang D
Steroids; 2013 Sep; 78(9):860-5. PubMed ID: 23685089
[TBL] [Abstract][Full Text] [Related]
37. Chemical components and against alzheimer's disease effects of the calyxes of Physalis alkekengi L. var. franchetii (Mast.) Makino.
Teng Y; Gao J; Tan T; Zhang X; Wang Y; Zhang J; Ni L
J Chem Neuroanat; 2024 Mar; 136():102390. PubMed ID: 38228242
[TBL] [Abstract][Full Text] [Related]
38. Isolation and quantitative analysis of physalin D in the fruit and calyx of Physalis alkekengi L.
Laczkó-Zöld E; Forgó P; Zupkó I; Sigrid E; Hohmann J
Acta Biol Hung; 2017 Sep; 68(3):300-309. PubMed ID: 28901802
[TBL] [Abstract][Full Text] [Related]
39. First Report of Powdery Mildew Caused by Golovinomyces magnicellulatus var. magnicellulatus on Physalis alkekengi var. franchetii in China.
Liang C; Xing HH; Liu Z; Cho SE; Shin HD
Plant Dis; 2013 Oct; 97(10):1382. PubMed ID: 30722154
[TBL] [Abstract][Full Text] [Related]
40. Antidiabetic potential of the ethyl acetate extract of Physalis alkekengi and chemical constituents identified by HPLC-ESI-QTOF-MS.
Zhang Q; Hu XF; Xin MM; Liu HB; Sun LJ; Morris-Natschke SL; Chen Y; Lee KH
J Ethnopharmacol; 2018 Oct; 225():202-210. PubMed ID: 29981847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
